Bazojoo V, Davoudi V, Blumenfeld JD, Zhu C, Malha L, Lo GC, Chevalier JM, Shimonov D, Sharbatdaran A, Dev H, Raza SI, Hu Z, He X, RoyChoudhury A, Prince MR. Effects of Pregnancy on Liver and Kidney Cyst Growth Rates in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study. J Clin Med 2025;14:3688, PMID: 40507450.
Sattar U, Zhu C, Yin X, Luo X, Bazojoo V, Prince AS, Rennert H, Brandman D, Schonfeld E, Blumenfeld JD, Prince MR. Common bile duct dilatation on MRI in autosomal dominant polycystic kidney disease. Abdom Radiol (NY) 2025 Jul 17, PMID: 40676196.
Hu Z, Lane EG, Lo GC, Blumenfeld JD, Shimonov D, Chevalier JM, Schonfeld EA, Brandman D, Prince MR. Reporting ADPK disease phenotypes on abdominal scans. Kidney Int Rep. 2025;10(9):2967-2976.
Xiong Q, He X, Scalco E, Pasini S, Zhu C, Moghadam MC, Sattar U, Davoudi V, Bazojoo V, Dev H, Shen M, Hu Z, Shih S, Prince SJ, Blumenfeld JD, Min RJ, Chevalier JM, Shimonov D, Lepping RJ, Yu ASL, Sabuncu MR, Caroli A, Prince MR. Automatically measuring kidney, liver, and cyst volumes in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2025, Nov 4. Online ahead of print.
Danda V, Tummalapalli SL. Impact of a CKD Population Health Intervention on Healthcare Utilization and Costs. Clin J Am Soc Nephrol. 2025 Jul10;20(8):1033-1035.
Wu S, Tedrow N, Bhalla A, Devito A, Wright S, Selbach F, Dadhania DM, Li C, Srivatana V, Silberzweig J, Lee JR. A Staphylococcus Dominant Nasal Microbiota in Hemodialysis Patients. Kidney Med. 2025 Sep 19;7(10):101079.
Carroll TJ, Oxburgh L, Kreidberg JA, Marciano DK. The Development of the Kidney. In Seldin and Giebisch’s The Kidney 6th Edition 2025. Editors: Alpern RJ, Caplan MJ, Moe OW, Quaggin SE.
Gordon D, Haynes C, Blumenfeld J, Finch SJ. PAWE-3D: Visualizing power for association with error in case/control genetic studies of complex traits. Bioinformatics 2005: 21:3935-3937.
Tan Y-C, Blumenfeld J, Anghel R, Donahue S, Belenkaya R, Parker T, Levine D, Leonard GBD, Renner H. Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease. Hum Mutat 2009;30:264-73.
Blumenfeld JD. Pretransplant genetic testing of live kidney donors at risk for autosomal dominant polycystic kidney disease. Transplantation 2009;87:6-7.
Poster D, Kistler A, Krauer F, Blumenfeld JD, Rennert H, Weishaupt D, Wuthrich R, Serra A. Kidney function and volume progression in unilateral ADPKD with contralateral renal agenesis or hypoplasia: a case series. Am J Kidney Dis. 2009 Sep;54(3):450-8.
Tan Y-C, Blumenfeld JD, Alber M, Donahue S, Balina M, Parker T, Levine D, Rennert H. Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal dominant polycystic kidney disease. Clin Genet. 2011;80:287-292.
Blumenfeld JD, Tepler J, Mauer A, Coller B, Bichet DG, Smith B. Tolvaptan inhibition of desmopressin effects on coagulation factors in a patient with decreased von Willebrand factor and polycystic kidney disease. Blood. 2011 Jul 14;118(2):474-6.
Higashihara E, Torres VE, Chapman AB, Grantham JJ, Bae K, Watnick TJ, Horie S, Nutahara K, Ouyang J, Krasa HB, Czerwiec FS; for the TEMPO4 156-05-002 Study Investigators. Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years’ Experience. Clin J Am Soc Nephrol. 2011;6(10):2499-507. Dr. Blumenfeld was the PI for the Rogosin study site.
Tan Y.C., Blumenfeld J., Michaeel A., Donahue S., Parker T., Levine D., and Rennert H. A novel, long-range PCR sequencing method for genetic analysis of the entire PKD1 gene. J Mol. Diag., 2012;14:305-313.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higarahihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec F, for the TEMPO 3:4 Trial Investgators. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2012; 367(25):2407-18. Dr. Blumenfeld was the PI for the Rogosin study site.
Tan AY, Michaeel A, Liu G, Elemento O, Blumenfeld J, Donahue S, Parker T, Levine D, Rennert H. Molecular diagnosis of autosomal dominant polycystic kidney disease using next-generation sequencing. J Mol Diagn. 2014 Mar;16(2):216-28. doi: 10.1016/j.jmoldx.2013.10.005. Epub 2013 Dec 27.
Ben-Dov IZ, Tan Y-C, Morozov P, Wilson PD, Rennert H, Blumenfeld JD, Tuschl T. Urine microRNA as potential biomarkers of autosomal dominant polycstic kidney disease progression: description of miRNA profiles at baseline. PLoS One; 2014:9:e86856.
Liu G, Tan AY, Michaeel A, Blumenfeld J, Donahue S, Bobb W, Parker T, Levine D, Rennert H. Development and validation of a whole genome amplification long-range PCR sequencing method for ADPKD genotyping of low-level DNA samples. Gene. 2014;550(1):131-5.
Tan AY, Blumenfeld J, Michaeel A, Donahue S, Bobb W, Parker T, Levine D, Rennert H. Autosomal dominant polycystic kidney disease caused by somatic and germline mosaicism. Clin Genet. 2015;87:373-7.
Reig B, Blumenfeld J, Donahue NP, Prince MR. Seminal megavesicle in autosomal dominant polycystic kidney disease. Clin Imaging 2015;39:289-92.
Thimmappa N, Blumenfeld J, Cerilles MA, Dunning A, Donahue SL, Zhang H, Prince M. Correlation of autosomal dominant polycystic kidney disease with cisterna chyli enlargement. J Mag Reson Imaging. 2015;41(1):142-8.
Zhang W, Tan A, Blumenfeld J, Liu G, Michaeel A, Zhang T, Robinson B, Salvatore S, Kapur S, Donahue S, Bobb W, Rennert H. Papillary renal cell carcinoma with a somatic mutation in c-MET in a patient with autosomal dominant polycystic kidney disease. Cancer Genetics 2016;209:11–20.
Kim JA, Blumenfeld JD, Chhabra S, Dutruel S, Thimmappa ND, Bobb W, Donahue S, Rennert HE, Tan AY, Giambrone AE, Prince MR. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations. Radiology. 2016 Apr 5:151650.
Farooq Z, Behzadi AH, Blumenfeld JD, Zhao Y, Prince MR. Complex liver cysts in autosomal dominant polycystic kidney disease. Clin Imaging 2017;46:98-101
Farooq Z, Behzadi AH, Blumenfeld JD, Zhao Y, Prince MR. Comparison of MRI segmentation techniques for measuring liver cyst volumes in autosomal dominant polycystic kidney disease. Clin Imaging 2017;47:41-46.
Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N Engl J Med 2017;377:1930-42. Dr. Blumenfeld was the PI for the Rogosin study site.
Tan A-Y, Zhang T, Michaeel A, Blumenfeld J, Liu G, Zhang W, Zhang Z, Zhiu Y, Rennert L, Martin C, Xiang J, Salvatore S, Robinson BD, Kapur S, Donahue S, Bobb WO, Rennert H. Somatic mutations in renal cyst epithelium in autosomal dominant polycystic kidney disease. J Am Soc Nephrol, 2018;29:2139-2156. PMID:30042192.
Raza SI, Behzadi AH, Blumenfeld JD, Girardi SK, Prince MR. Bladder diverticuli following injection of onabotulinum toxin A in a patient with multiple sclerosis and autosomal dominant polycystic kidney disease. Radiol Case Rep. 2018; 13:1021-1024. PMID: 30228836.
Zhang W, Stephens CJ, Blumenfeld JD, Behzadi AH, Donahue S, Bobb W), Newhouse JH, Rennert H, Zhao Y, Prince MR. Relationship of seminal megavesicles, prostate median cysts and genotype in autosomal dominant polycystic kidney disease. J Mag Reson Imaging 2019; 49:894-903. PMID 30230107.
Yin X, Prince WK, Blumenfeld JD, Zhang W, Donahue S, Bobb WO, Rennert H, Askin G, Barash I, Prince MR. Spleen phenotype in autosomal dominant polycystic kidney disease. Clin Radiol. 2019;74(12):975.e17-975.e24. PMID:31563290
Yin X, Blumenfeld JD, Riyahi S, Luo X, Rennert H, Barash I, Prince MR. Prevalence of inferior vena cava compression in ADPKD. Kidney Int Rep 2020;6(1):168-178. PMID:33426396
Riyahi S, Dev H, Blumenfeld JD, Rennert H, Yin X, Attari H, Barash I, Chicos I, Bobb W, Donahue S, Prince MR. Hemorrhagic cysts and other MR biomarkers for predicting renal dysfunction progression in autosomal dominant polycystic kidney disease. J Magn Reson Imaging. 2021 53(2):564-576. PMID: 32969110
Zhang Z, Bai H, Blumenfeld J, Ramnauth A, Barash I, Prince M, Tan AY, Michaeel A, Liu G, Chicos I, Giannakopoulos S, Larbi K, Hughes S, Salvatore SP, Robinson BD, Kapur S, Rennert H. Detection of PKD1 and PKD2 somatic variants in autosomal dominant polycystic kidney disease cyst epithelial cells by whole genome sequencing. JASN, 32:3114-3129, 2021.
Liu J,Fujikura K, Dev Hreedi, Riyahi S, Blumenfeld J, Kim J, Rennert H, Prince MR. Pericardial effusion on MRI in autosomal dominant polycystic kidney disease. J Clin Med 2022;11:1127-1138.
Goel A, Shih G, Riyahi S, Jeph S, Dev H, Hu R, Romano D, Teichman K, Blumenfeld JD, Barash I, Chicos I, Rennert H, Prince M. Deployed deep learning kidney segmentation for polycystic kidney disease MRI. Radiology: Artificial Intelligence 2022, 4(2):e210205.
Sharbatdaran A, Romano D, Teichman K, Dev H, Raza SI, Goel A, Moghadam MC, Blumenfeld JD, Chevalier JM, Shimonov D, Shih G, Wang Y, Prince MR. Deep learning automation of kidney, liver, and spleen segmentation for organ volume measurements in autosomal dominant polycystic kidney disease. Tomography. 2022 Jul 13;8(4):1804-1819. doi: 10.3390/tomography8040152. PMID: 35894017
Zhang Z, Blumenfeld J, Ramnauth A, Barash I, Zhou Pengbo, Levine D, Parker T, Rennert H. A common intronic single nucleotide variant modifies PKD1 expression level. Clin Genet 2022;102:483-493.
Liu J, Yin X, Dev H, Luo X, Blumenfeld JD, Rennert H, Prince MR. Pleural effusions on MRI in autosomal dominant polycystic kidney disease. J Clin Med 2023;12:386. doi 10.3390/jcm12010386.
Dev H, Zhu C, Charbatdaran A, Raza SI, Wanf SJ, Romano DJ, Goel A, Teichman K, Moghadam MC, Shih G, Blumenfeld JD, Shimonov D, Chevalier JM, Prince MR. Effect of averaging measurements from multiple MRI pulse sequences on kidney volume reproducibility in autosomal dominant polycystic kidney disease J Magn Reson Imaging 2023;doi: 10.1002/jmri.28593. PMID: 36645114.
Dev H, Zhu C, Sharbatdaran A, Raza SI, Wang SJ, Romano DJ, Goel A, Teichman K, Moghadam MC, Shih G, Blumenfeld JD, Shimonov D, Chevalier JM, Prince MR. Clinical quality control of MRI total kidney volume measurements in autosomal dominant polycystic kidney disease. Tomography 2023;9:1341-1355. PMID: 37489475
He X, Hu Z, Dev H, Romano DJ, Sharbatdaran A, Raza SI, Wang SJ, Teichman K, Shih G, Chevalier JM, Shimonov D, Blumenfeld JD, Goel A, Sabuncu MR, Prince MR. Test re-test reproducibility of organ volume measurements in ADPKD using 3DMultimodality Deep Learning. Acad Radiol 2023; PMID: 37798206
Schumacher K, Prince MR, Blumenfeld JD, Rennert H, Hu Z, Dev H, Wang Y, Dimov AV. Quantitative susceptibility mapping for detection of kidney stones, hemorrhage differentiation, and cyst classification in ADPKD. Abdom Radiol (NY). 2024 Mar 26 PMID: 38530430.
Dev H, Zhu C, Barash I, Blumenfeld JD, He X, RoyChoudhury A, Wu A, Prince MR. Feasibility of water therapy for slowing autosomal dominant polycystic kidney disease progression. Kidney360. 2024 Apr 1. PMID: 38556640.
Hu Z, Sharbatdaran A, He X, Zhu C, Blumenfeld JD, Rennert H, Zhang Z, Ramnauth A, Shimonov D, Chevalier JM, Prince MR. Improved predictions of total kidney volume growth rate in ADPKD using two-parameter least squares fitting. Sci Rep. 2024 Jun 14;14(1):13794. PMID: 38877066
Zhu C, He X, Blumenfeld JD, Hu Z, Dev H, Sattar U, Bazojoo V, Sharbatdaran A, Aspal M, Romano D, Teichman K, Ng He HY, Wang Y, Soto Figueroa A, Weiss E, Prince AG, Chevalier JM, Shimonov D, Moghadam MC, Sabuncu M, Prince MR. A primer for utilizing deep learning and abdominal MRI imaging features to monitor autosomal dominant polycystic kidney disease progression. Biomedicines. 2024 May 20;12(5):1133. PMID: 38791095
Hu Z, Sharbatdaran A, He X, Zhu C, Blumenfeld JD, Rennert H, Zhang Z, Ramnauth A, Shimonov D, Chevalier JM, Prince MR. Improved predictions of total kidney volume growth rate in ADPKD using two-parameter least squares fitting. Sci Rep. 2024 Jun 14;14(1):13794. PMID: 38877066.
Sattar U, Yin X, Luo X, Zhu C, Hu Z, Blumenfeld JD, Rennert H, Wu A, RoyChoudhury A, Salama G, Prince MR. Prevalence of spinal meningeal diverticula in autosomal dominant polycystic kidney disease. AJNR Am J Neuroradiol. 2024 Jul 11:ajnr.A8407. doi: 10.3174/ajnr.A8407. Online ahead of print. PMID: 38991774
Wang SJ, Hu Z, Li C, He X, Zhu C, Wang Y, Sattar U, Bazojoo V, He HYN, Blumenfeld JD, Prince MR. Automatically detecting pancreatic cysts in autosomal dominant polycystic kidney disease on MRI using deep learning. Tomography. 2024 Jul 16;10(7):1148-1158.
Bazojoo V, Davoudi V, Blumenfeld JD, Zhu C, Malha L, Lo GC, Chevalier JM, Shimonov D, Sharbatdaran A, Dev H, Raza SI, Hu Z, He X, RoyChoudhury A, Prince MR. Effects of Pregnancy on Liver and Kidney Cyst Growth Rates in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study. J Clin Med 2025;14:3688, PMID: 40507450.
Sattar U, Zhu C, Yin X, Luo X, Bazojoo V, Prince AS, Rennert H, Brandman D, Schonfeld E, Blumenfeld JD, Prince MR. Common bile duct dilatation on MRI in autosomal dominant polycystic kidney disease. Abdom Radiol (NY) 2025 Jul 17, PMID: 40676196.
Hu Z, Lane EG, Lo GC, Blumenfeld JD, Shimonov D, Chevalier JM, Schonfeld EA, Brandman D, Prince MR. Reporting ADPK disease phenotypes on abdominal scans. Kidney Int Rep. 2025;10(9):2967-2976.
Xiong Q, He X, Scalco E, Pasini S, Zhu C, Moghadam MC, Sattar U, Davoudi V, Bazojoo V, Dev H, Shen M, Hu Z, Shih S, Prince SJ, Blumenfeld JD, Min RJ, Chevalier JM, Shimonov D, Lepping RJ, Yu ASL, Sabuncu MR, Caroli A, Prince MR. Automatically measuring kidney, liver, and cyst volumes in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2025, Nov 4. Online ahead of print.
Danda V, Tummalapalli SL. Impact of a CKD Population Health Intervention on Healthcare Utilization and Costs. Clin J Am Soc Nephrol. 2025 Jul10;20(8):1033-1035.
Wu S, Tedrow N, Bhalla A, Devito A, Wright S, Selbach F, Dadhania DM, Li C, Srivatana V, Silberzweig J, Lee JR. A Staphylococcus Dominant Nasal Microbiota in Hemodialysis Patients. Kidney Med. 2025 Sep 19;7(10):101079.
Carroll TJ, Oxburgh L, Kreidberg JA, Marciano DK. The Development of the Kidney. In Seldin and Giebisch’s The Kidney 6th Edition 2025. Editors: Alpern RJ, Caplan MJ, Moe OW, Quaggin SE.